cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Karyopharm Therapeutics Inc
16 own
24 watching
Current Price
$1.38
$0.28
(25.45%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
135.35M
52-Week High
52-Week High
4.87000
52-Week Low
52-Week Low
0.61700
Average Volume
Average Volume
3.15M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
21.0465
iconMarket Capitalization135.35M
icon52-Week High4.87000
icon52-Week Low0.61700
iconAverage Volume3.15M
iconDividend Yield--
iconP/E Ratio21.0465
What does the Karyopharm Therapeutics Inc do?
Karyopharm Therapeutics Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of drugs directed against nuclear transport and related targets for the treatment of cancer and other diseases. Its lead drug candidate is Selinexor, which is in Phase IIb clinical trial for patients with heavily pretreated multiple myeloma; Phase Ib/II clinical study in combination with backbone treatments for relapsed/refractory multiple myeloma; Phase II/III clinical trial for patients with relapsed and/or refractory multiple myeloma; Phase II clinical study to treat acute myeloid leukemia; Phase IIb clinical trial for patients with diffuse large B-cell lymphoma; and Phase II/III clinical trial to treat liposarcoma. The company is also developing KPT-8602 that is in Phase I/II study for patients with relapsed/refractory multiple myeloma; KPT-9274, which is in Phase I clinical trial for patients with advanced solid malignancies or non-Hodgkin's lymphoma; KPT-335, which is in Phase I clinical trial for the treatment of viral indications; and KPT-350 that is in preclinical stage to treat neurological disorders, and inflammatory and autoimmune diseases. Karyopharm Therapeutics Inc. was founded in 2008 and is headquartered in Newton, Massachusetts.
Read More
How much money does Karyopharm Therapeutics Inc make?
News & Events about Karyopharm Therapeutics Inc.
Zolmax
9 months ago
Karyopharm Therapeutics (NASDAQ:KPTI Get Rating) and Gracell Biotechnologies (NASDAQ:GRCL Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, profitability, earnings, dividends, institutional ...
PR Newswire
11 months ago
Karyopharm Announces Presentation of Interim Data from Phase 2 Study of Single-Agent Eltanexor in Relapsed/Refractory (R/R) Higher-Risk Myelodysplastic Neoplasms (MDS) at 17th International Congress on MDS Karyopharm Announces Presentation of Interim Data from Phase 2 Study of Single-Agent...
PR Newswire
1 year ago
Karyopharm Announces Presentation of Updated Phase 1 Selinexor Data in Patients with Treatment-Nave Myelofibrosis at AACR 2023 Karyopharm Announces Presentation of Updated Phase 1 Selinexor Data in Patients with Treatment-Nave Myelofibrosis at AACR 2023 PR Newswire NEWTON, Mass., April 18, 2023 At...
PR Newswire
1 year ago
Karyopharm To Present Data from Phase 1 Study of Selinexor in Patients with Treatment-Nave Myelofibrosis at AACR and to Host Investor Webcast on April 18th Karyopharm To Present Data from Phase 1 Study of Selinexor in Patients with Treatment-Nave Myelofibrosis at AACR and to Host Investor Webcast...
PR Newswire
1 year ago
Karyopharm and Menarini Group Receive Full Marketing Authorization from the UK Medicines & Healthcare Products Regulatory Agency for NEXPOVIO (selinexor) in Combination with Bortezomib and Dexamethasone for the Treatment of Adult Patients with Multiple Myeloma Who Have Received at Least One...
Frequently Asked Questions
Frequently Asked Questions
What is Karyopharm Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Karyopharm Therapeutics Inc shares?
plus_minus_icon
How can I buy Karyopharm Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Karyopharm Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Karyopharm Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Karyopharm Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Karyopharm Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Karyopharm Therapeutics Inc?
plus_minus_icon
What percentage is Karyopharm Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Karyopharm Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.38
$0.28
(25.45%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00